The insulin, peroxisome proliferator-activated receptor (PPAR), p53, and mitogen-activated protein kinase (MAPK) signaling pathways form a complex web that plays a pivotal role in the development of NAFLD and its progression to NASH [57]. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatohepatitis.